NCT06133283

Brief Summary

This study aims to determine the effects of aerobic exercise as a primer to add-on virtual reality (VR)-based rehabilitation on balance, postural control and neuroplasticity (ability of brain to adapt in structure and function) in individuals with Parkinson's disease (PD). This study will utilize two groups - one group will receive the exercise and VR, while the other group will receive stretching exercise and VR over eight weeks. The study team will administer outcomes at baseline, post-intervention (8 weeks) and follow-up (6 weeks after post-assessment).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
8mo left

Started Feb 2024

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

November 7, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

February 9, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

2.9 years

First QC Date

November 7, 2023

Last Update Submit

March 26, 2026

Conditions

Keywords

Aerobic exerciseVirtual realityRehabilitationBalanceNeurophysiology

Outcome Measures

Primary Outcomes (1)

  • Balance

    Balance will be tested with the Mini Balance Evaluation Systems Test(miniBESTest), involving 14 different tasks including the timed up and go test to assess static and dynamic balance. Scores range from 0 to 28 with higher scores suggesting better balance.

    Baseline, post (8 week), follow-up (14 weeks)

Secondary Outcomes (8)

  • Postural stability

    Baseline, post (8 week), follow-up (14 weeks)

  • Endurance

    Baseline, post (8 week), follow-up (14 weeks)

  • Spatiotemporal gait parameters

    Baseline, post (8 week), follow-up (14 weeks)

  • Brain derived neurotrophic growth factor (BDNF)

    Baseline, post (8 week), follow-up (14 weeks)

  • Corticomotor excitability

    Baseline, post (8 week), follow-up (14 weeks)

  • +3 more secondary outcomes

Study Arms (2)

High intensity endurance exercise and virtual reality (experimental)

EXPERIMENTAL

The exercise group will perform high intensity interval exercise and VR-based games 3 times a week for 8 weeks.

Behavioral: High intensity endurance exerciseBehavioral: Virtual reality (VR)-based gaming

Stretching and virtual reality (control)

OTHER

The stretching group will perform stretching exercises and VR-based games 3 times a week for 8 weeks.

Behavioral: Stretching exerciseBehavioral: Virtual reality (VR)-based gaming

Interventions

High intensity interval exercise on a recumbent stepper for 30 minutes, 3 days per week.

High intensity endurance exercise and virtual reality (experimental)

Stretches of face, neck, upper extremity, trunk and lower extremity muscles including whole body stretches for 30 minutes, 3 days per week.

Stretching and virtual reality (control)

VR games will involve games that challenge balance such as reaching different targets during activities such as sit to stand, dodging obstacles etc. Participants will play approximately 6 games for 30 minutes, 3 days a week.

High intensity endurance exercise and virtual reality (experimental)Stretching and virtual reality (control)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic PD (ages 18 -85) in Hoehn and Yahr stages 2 - 3.
  • Subjects need to demonstrate a score of equal to or greater than 23 on the Mini Mental State Examination.
  • Subjects who have a score of ≤21.5 on the Mini Balance Evaluations Systems Test (miniBESTest).

You may not qualify if:

  • Subjects with a history of other neurological diseases (i.e., stroke, multiple sclerosis).
  • Subjects with a history of severe cardiopulmonary disease, uncontrolled hypertension, orthostatic hypotension, uncontrolled diabetes, severe osteoporosis, severe arthritis affecting their lower extremity joints.
  • Subjects with a history of PD-specific surgical procedures such as deep brain stimulation etc.
  • Subjects with a history of head injury.
  • Subjects with a history of seizures or epilepsy.
  • Subjects who are currently pregnant.
  • Individuals who use of medications that could alter corticomotor excitability or increase risk of seizure.
  • Individuals with skull abnormalities, fractures or unexplained, recurring headaches.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT Health San Antonio- Dept. of Physical Therapy

San Antonio, Texas, 78229, United States

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Interventions

Muscle Stretching Exercises

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Anjali Sivaramakrishnan

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anjali Sivaramakrishnan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will utilize a randomized controlled design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2023

First Posted

November 15, 2023

Study Start

February 9, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 31, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

All collected deidentified individual participant data (IPD) will be shared on an open source platform and summary results will be shared on ClinicalTrials.gov.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Upon publication of the study findings.

Locations